13 results
DRS
EX-3.3
CRBU
Caribou Biosciences Inc
7 May 21
Draft registration statement
12:00am
Without a Meeting
Nominations for Board of Directors
Directors
Powers
Number; Election; Tenure and Qualification
Vacancies and Newly Created Directorships …
Officers
Enumeration
Election
Appointment of Other Agents
Compensation
Tenure
Chairman of the Board and Vice-Chairman of the Board
President
Vice
S-1
EX-3.3
CRBU
Caribou Biosciences Inc
1 Jul 21
IPO registration
4:05pm
Without a Meeting
Nominations for Board of Directors
Directors
Powers
Number; Election; Tenure and Qualification
Vacancies and Newly Created Directorships …
Officers
Enumeration
Election
Appointment of Other Agents
Compensation
Tenure
Chairman of the Board and Vice-Chairman of the Board
President
Vice
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
25 Aug 21
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors
4:11pm
ADCETRIS, PADCEV, TUKYSA, tisotumab vedotin, and ladiratizumab vedotin. Prior to her tenure in the biopharmaceutical industry, she had a career
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
11 May 22
Caribou Biosciences Announces Appointment of David Johnson
4:07pm
treatments Complera® and Stribild®. Before Gilead, Mr. Johnson had an 11-year tenure at Glaxo Smith Kline, where he held various positions in sales, product
S-1/A
EX-3.5
CRBU
Caribou Biosciences Inc
19 Jul 21
IPO registration (amended)
6:09am
Organization
ARTICLE V OFFICERS
5.1 Officers Designated
5.2 Tenure and Duties of Officers
(a) General
(b) Duties of Chief Executive Officer
(c) Duties … Tenure and Duties of Officers.
(a) General. All officers shall hold office at the pleasure of the Board of Directors and until their successors shall
8-K
EX-3.2
pslm60 avdwse4m
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
DEF 14A
i702z iz5cdz
11 Aug 22
Definitive proxy
4:04pm
S-1
EX-10.26
lv6i2iz
1 Jul 21
IPO registration
4:05pm
8-K
EX-10.1
nqk21asyz ts
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
DRS
EX-10.23
fc5kbe 5u9wzrnloi6du
7 May 21
Draft registration statement
12:00am
10-K
taaa7p4gr3v9m
21 Mar 22
Annual report
4:19pm
- Prev
- 1
- Next